Any consideration of GLP-1 therapy should involve comprehensive evaluation by an endocrinologist or appropriate specialist, with clear discussion of the investigational nature of this approach, potential risks, costs, and the importance of ongoing monitoring
Food & Drug AdministrationGHK-Cu is not an FDA-approved drug for injection
Only increase if weight loss stalls for 3 or more consecutive weeks, appetite suppression fades before your next injection, or your prescriber recommends escalation based on your individual progress
For meaningful biological activity, look for oils with verified polyphenol content of at least 500 mg/kg
The pricing differential covers the compounding pharmacy sourcing, the prescription itself, the medical evaluation, the InBody scan, the kit with reconstitution supplies, and the structured 3-month protocol
Pathway 1: Manufacturer Patient Assistance Programs (PAPs) One of the first places people often look is directly at the source: the drug manufacturers themselves